{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:07:44Z","timestamp":1761512864485},"reference-count":7,"publisher":"Informa Healthcare","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1517\/14656566.2010.512006","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T13:07:55Z","timestamp":1281704875000},"page":"2569-2572","source":"Crossref","is-referenced-by-count":17,"title":["Mipomersen as a potential adjunctive therapy for hypercholesterolemia"],"prefix":"10.1517","volume":"11","author":[{"given":"Neeraj","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2010,8,13]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","volume":"11","author":"Raal FJ","year":"2010","journal-title":"Lancet"},{"key":"CIT0002","first-page":"2863","volume-title":"The metabolic and molecular basis of inherited disease","author":"Goldstein JL","year":"2001","edition":"8"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318925"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.02.009"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061189"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.606442"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M002915"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2010.512006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T12:33:29Z","timestamp":1497875609000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2010.512006"}},"subtitle":["Evaluation of: \u2018Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.\u2019 Lancet 2010;375:998-1006"],"short-title":[],"issued":{"date-parts":[[2010,8,13]]},"references-count":7,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2010,8,13]]},"published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1517\/14656566.2010.512006"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2010.512006","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,13]]}}}